Workflow
Analysts Name 9 'Left Out' Stocks With Huge Upside Ahead
ModernaModerna(US:MRNA) Investorsยท2025-10-29 12:00

Core Insights - Analysts identify nine S&P 500 stocks that have declined 30% or more this year, including Moderna and Kenvue, which are expected to rally by 30% or more in the next 12 months [1][6]. Group 1: Market Performance - The S&P 500 has increased by 35% since its year-to-date low on April 8, 2025, and has risen over 92% since the bull market began on October 12, 2022, excluding dividends [2]. - Analysts are searching for stocks that have not yet fully participated in the current market rally [2]. Group 2: Company-Specific Analysis - Moderna's stock has dropped nearly 40% this year, with an expected earnings per share (EPS) decline of 4% [3]. - Despite the negative sentiment, analysts project a 59% upside for Moderna, targeting a price of 40.30 in 12 months [4]. - Kenvue's stock is down 32% this year, but analysts anticipate an 8% EPS increase in 2026, with a target price of 20.37, representing a 40.4% gain [4]. Group 3: Promising Stocks - The following "left out" S&P 500 stocks are expected to recover significantly: - Moderna (MRNA): YTD change -39.0%, 12-month upside 59.0% [6] - Alexandria Real Estate Equities (ARE): YTD change -35.5%, 12-month upside 52.6% [6] - GoDaddy (GDDY): YTD change -33.7%, 12-month upside 44.4% [6] - Kenvue (KVUE): YTD change -32.0%, 12-month upside 40.4% [6] - Fiserv (FI): YTD change -38.6%, 12-month upside 34.7% [6] - The Trade Desk (TTD): YTD change -56.0%, 12-month upside 34.6% [6] - Align Technology (ALGN): YTD change -36.1%, 12-month upside 31.5% [6] - Chipotle Mexican Grill (CMG): YTD change -33.2%, 12-month upside 31.4% [6] - Oneok (OKE): YTD change -31.2%, 12-month upside 31.3% [6]